Daniel J. O'Connor Ambrx Biopharma Inc. (AMAM) insider trading activity

AMAM Quotes by TradingView

Daniel J. O'Connor is President and CEO of Ambrx Biopharma Inc.. Currently has a direct ownership of 2.75 Million shares of AMAM, which is worth approximately $77 Million. The most recent transaction as insider was on Apr 26, 2023, when has been sold 2,750,000 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.75M
0% 3M change
0% 12M change
Total Value Held $77 Million

Daniel J. O'Connor Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 26 2023
BUY
Grant, award, or other acquisition
-
2,750,000 Added 50.0%
2,750,000 Ordinary Shares

Also insider at

SEEL
SEELOS THERAPEUTICS, INC. Healthcare
Director
ONCS
ONCOSEC MEDICAL Inc Healthcare
CEO and President
LSPR
Larkspur Health Acquisition Corp. Financial Services
Director
AMAM
Ambrx Biopharma, Inc.
President and CEO
DJO

Daniel J. O'Connor

President and CEO
Pennington, NJ

Track Institutional and Insider Activities on AMAM

Follow Ambrx Biopharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMAM shares.

Notify only if

Insider Trading

Get notified when an Ambrx Biopharma Inc. insider buys or sells AMAM shares.

Notify only if

News

Receive news related to Ambrx Biopharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AMAM